These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9577944)

  • 1. Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy.
    Kyriakidis M; Triposkiadis F; Dernellis J; Androulakis AE; Mellas P; Kelepeshis GA; Gialafos JE
    Circulation; 1998 Apr; 97(14):1342-7. PubMed ID: 9577944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme.
    Eberli FR; Apstein CS; Ngoy S; Lorell BH
    Circ Res; 1992 May; 70(5):931-43. PubMed ID: 1314716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
    Friedrich SP; Lorell BH; Rousseau MF; Hayashida W; Hess OM; Douglas PS; Gordon S; Keighley CS; Benedict C; Krayenbuehl HP
    Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy.
    Haber HL; Powers ER; Gimple LW; Wu CC; Subbiah K; Johnson WH; Feldman MD
    Circulation; 1994 Jun; 89(6):2616-25. PubMed ID: 8205673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.
    Piana RN; Wang SY; Friedman M; Sellke FW
    Circulation; 1996 Feb; 93(3):544-51. PubMed ID: 8565174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute angiotensin-converting enzyme inhibition on diastolic ventricular interaction in the dilated heart.
    Pepi M; Tamborini G; Maltagliati A; Guazzi M; Berna G; Susini F; Muratori M; Celeste F
    Clin Cardiol; 2003 Sep; 26(9):424-30. PubMed ID: 14524600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.
    Foult JM; Tavolaro O; Antony I; Nitenberg A
    Circulation; 1988 Feb; 77(2):337-44. PubMed ID: 2827913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
    Flesch M; Schiffer F; Zolk O; Pinto Y; Stasch JP; Knorr A; Ettelbrück S; Böhm M
    J Hypertens; 1997 Sep; 15(9):1001-9. PubMed ID: 9321748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalaprilat decreases plasma endothelin and atrial natriuretic peptide levels and preload in patients with left ventricular dysfunction after cardiac surgery.
    Tohmo H; Karanko M; Klossner J; Scheinin M; Viinamäki O; Neuvonen P; Ruskoaho H
    J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):585-90. PubMed ID: 9263090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy.
    Rouleau JR; Simard D; Blouin A; Kingma JG
    Basic Res Cardiol; 2002 Sep; 97(5):384-91. PubMed ID: 12200638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalaprilat improves the impaired left ventricular pump function during exercise in hypertensives with coronary microangiopathy and with coronary artery disease.
    Franz I; Tönnesmann U; Schaupp S; van der Meyden J
    Kidney Blood Press Res; 1998; 21(6):452-8. PubMed ID: 9933831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of coronary flow reserve after long-term therapy with enalapril.
    Motz W; Strauer BE
    Hypertension; 1996 May; 27(5):1031-8. PubMed ID: 8621193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.